Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360319940260050793
Journal of Korean Cancer Research Association
1994 Volume.26 No. 5 p.793 ~ p.800
Expression of p53 in the Benign and Malignant Tumor of Prostate


Abstract
Immunohistochemical expression of the p53 was studied in 20 cases of benign prostatic hypertrophy(BPH) and 56 prostatic adenocarcinomas using a monoclonal p53-specific DO7 antibody (Novocastra, U.K.) on formaline-fixed paraffin-embedded tissue
sections.
Proliferative activity was determined by immunohistochemical detection of proliferative cell nuclear antigen (PCNA) using a monoclonal PC10 antibody (Novocastra, U.K.) Eleven of 56 prostatic carcinomas(19.6%) showed strong immunostaining for p53
in
more
than 20% of tumor cells and 15(28.6%) had focal(¡Â20%) immunoreactivity. The glandular epithelium adjacent to carcinomas showed features of prostatic intraepithelial neoplasia which was stained positively for p53 in 25%, but all cases of BPH
showed
no
staining. High grade carcinomas(Gleason's combined score¡Ã7) were associated with more intense and extensive p53 staining. High PCNA staining(higher than 50%)showed more p53 immunoreactivity(81.8%) than those cases with lower PCNA staining(40%).
These findings indicate that altered expression of p53 protein occurs in a prostate cancer and is associated with increased proliferative activity and appears to play a role in the develpment of highly malignant prostatic carcinomas.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø